Roche: Matt Sause

Oct 03, 2022

Matt Sause, currently president and CEO of Roche Diagnostics' North America Region, will become CEO of Roche Diagnostics, effective Jan. 1, 2023. He will take over from Thomas Schinecker, who will become Roche's CEO on March 15. Sause previously served as lifecycle leader for Tecentriq Lung and Head and Neck Cancers at Roche subsidiary Genentech and has held a variety of commercial general management and global product leadership roles at Roche since he joined the company in 2002.

Breaking News

Roche: Matt Sause

Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations

Lucid Diagnostics Raises $22M in Convertible Debt Refinancing

Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit

Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint

Multi-Ancestry Study Uncovers Genetic Contributors to Progressive Eye Disease